Bonesupport
371,8
SEK
+0,81 %
BONEX
NASDAQ Stockholm
Medical Equipment & Services
Health Care
9 investorer følger denne virksomhed
+0,81%
+9,35%
+26,03%
+43,89%
+97,56%
+125,33%
+927,07%
+1.009,85%
+1.061,88%
www.bonesupport.com/en-eu/investors
Bone Support is active in medical technology. The company develops and commercializes injectable bioceramic bone graft substitutes that are transformed into the patient's bone and have the ability to release drugs. The company's bone graft substitutes are based on the technology platform Cerament. At present, the company conducts ongoing clinical studies. The company has sales in Europe and North America and is headquartered in Lund, Sweden.
Omsætning
591,08 mio.
EBIT %
2,36 %
P/E
98,62
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BONEX
Daglig lav / høj pris
365 / 372,2
SEK
Markedsværdi
24,82 mia. SEK
Aktieomsætning
19,47 mio. SEK
Volumen
53 t
Seneste videoer
Finanskalender
Årsrapport
25.02.2025
Delårsrapport
24.04.2025
Delårsrapport
15.07.2025
Delårsrapport
23.10.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
HealthCap | 9,9 % | 10,0 % |
Swedbank Robur Fonder | 9,0 % | 9,1 % |
Capital Group | 7,9 % | 8,0 % |
Handelsbanken Fonder | 4,1 % | 4,1 % |
Avanza Pension | 3,7 % | 3,7 % |
Norges Bank | 2,5 % | 2,5 % |
JP Morgan Asset Management | 2,4 % | 2,4 % |
SEB Investment Management | 2,0 % | 2,0 % |
Tredje AP-Fonden | 1,9 % | 1,9 % |
Erik Selin | 1,7 % | 1,7 % |
ViserAlle indholdstyper
Announced Insider Trading
Redeye: BONESUPPORT Q3 - Surprising on US sales and EBIT
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools